These final results, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the strategy of focusing on ACKR3 as a singular approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked disorders. Notice: Effects may https://asenacax951umd8.wikilowdown.com/user